News
Best Spiritual Apps for Growth: Online Psychic Readings, Meditation, and Yoga
Somewhere between waking and dreaming, the noise of the world, and the stillness of solitude, there is a space where the self expands. Spiritual growth is not about discovering something new but recognizing what was always there, waiting. Sometimes, you need a guide—a whisper in the wind, a reflection in the water, or, in our digital age, an app that helps navigate the unseen.
We live in a time where connection happens in curious ways. A psychic reading, a yoga session, a moment of meditation—they all exist in your pocket, waiting for the right moment to unfold. This article will discuss some of the best spiritual apps to accompany you on this journey.
Nebula, a spiritual guidance platform
There is something inherently human about looking for meaning in the stars, tracing invisible lines between them to form shapes that reflect our lives. Nebula, a spiritual guidance platform, does something similar.
Bringing together astrology, online psychic readings, and the quiet wisdom of the unseen, this app can become your companion on a path to spiritual development. It’s not just a tool but a portal where over 1000 psychics lend their insights to those seeking them.
A curious thing about Nebula is its client-psychic matching system, which feels less like an algorithm and more like a river guiding you toward the right shore. You answer a few questions, and suddenly, a name appears. Every professional has a profile with reviews from previous clients, so you’ll always be sure you’re in the right hands. Whether it’s tarot, aura readings, or palmistry, the experience is more than just a reading; it is an echo of something you already knew, deep inside.
In addition to readings, Nebula also provides daily horoscopes, compatibility reports, and educational tarot content, making it a well-rounded spiritual resource.
Nebula is also generous to newcomers. The first three minutes with an advisor are free, a quiet invitation into the unknown. Beyond that, an 80% discount on your first session makes it easy to take the next step. If you are curious, you can explore Nebula and even step into a free psychic reading online chat no credit card required.
Down Dog: Yoga for the Wandering Mind
Some practices take years to master, but others meet you where you are. Down Dog is one of the latter.
The app adapts to you: your experience level, mood, and body’s quiet requests. Some days, it will guide you into deep stretches that unlock forgotten corners of yourself; other days, it will simply help you breathe. It offers customizable sessions that can be tailored to focus on strength, flexibility, or relaxation, ensuring that your practice aligns with your needs.
The interface is simple, the narration calming, like a quiet companion reminding you that the body holds stories worth listening to.
Yoga for Beginners: The First Step
Beginnings are quiet things. Yoga for Beginners understands this and offers simple, structured sessions that feel more like a gentle introduction than an overwhelming plunge.
The app guides you with voice instructions, giving you just enough direction to move forward without overcomplicating the path. If the idea of yoga has always seemed too complex or intimidating, this app ensures you start small—one breath, one pose at a time.
Calm: A Soft Place to Land
The world can be loud, but silence is always available if you know where to look. Calm is a reminder of that.
It is a collection of quiet spaces: guided meditations, sleep stories narrated in hushed tones and breathing exercises that feel like the whisper of a familiar wind. For those who struggle with insomnia or anxiety, Calm provides a soothing retreat, a small corner of peace in a world that often moves too fast.
Headspace: The Art of Structured Stillness
Some people find peace in routine. Headspace offers a structured approach to meditation that feels like carefully arranged stones in a Zen garden. It teaches you the art of mindful living, gently guiding you through sessions on stress, focus, and sleep.
What makes Headspace stand out is its focus on progression: you can start with just a few minutes a day, gradually increasing the length and depth of your practice. It turns meditation into a habit, making mindfulness as natural as breathing.
Finding Yourself in the Digital Age
We seek meaning in strange places: between the pages of an old book, in the warmth of a stranger’s voice, in the quiet space of a morning before the world wakes.
These apps are not answers; they are doorways. If you are looking for an answer from the stars, Nebula is the key. If your body aches for movement, yoga will answer. If your mind craves stillness, meditation will provide it.
Perhaps, in this search for spiritual guidance, you’ll find yourself listening more closely—to the world, to others, and most importantly, to yourself. Growth is not always loud. Sometimes, it is as quiet as a breath, as small as a single choice. The right app and the right moment might change everything.
An early PET scan after one cycle of chemotherapy may help predict how aggressive breast cancer responds to treatment, a study suggests.
Research led by The Institute of Cancer Research, London and King’s College London suggests that an early scan taken after one cycle of chemotherapy could help predict how well a patient’s cancer will respond to treatment.
The study focused on patients with triple-negative breast cancer (TNBC), an aggressive form of the disease in which cancer cells lack receptors for the hormones oestrogen and progesterone, as well as the HER2 protein.
Patients with TNBC are usually treated with chemotherapy prior to surgery. While many respond well, residual disease at surgery, typically around six months later, is associated with a significantly poorer prognosis. Identifying people sooner who are unlikely to respond remains a major clinical challenge.
The research explored whether using PET imaging shortly after treatment begins, rather than relying only on MRI scans later in the treatment process, could provide earlier insight into how a patient’s cancer is responding. Twenty-two patients were recruited, with fourteen undergoing FDG-PET scans before treatment and after the first cycle of chemotherapy.
The findings, published in Clinical Cancer Research, showed that changes seen on PET scans after just one cycle of chemotherapy were strongly associated with subsequent response, including whether there was no detectable cancer, known as a complete response, by the end of treatment. Importantly, early PET response showed stronger associations with treatment outcomes than standard mid-treatment MRI scans in this study.
Being able to identify patients who are not responding well at an early stage could allow clinicians to adjust treatment sooner or consider alternative approaches. These findings may also support future strategies to better tailor treatment intensity to individual patients.
The study also compared two types of PET tracers, FDG and FLT, to determine which was most suitable. While both met the study’s technical criteria, FDG-PET was selected for further evaluation due to its better image quality, greater consistency and wider use in clinical practice.
The research also explored how imaging changes after just one cycle of chemotherapy relate to the body’s immune response to treatment. Biopsies taken before and after the first cycle of chemotherapy showed that an increase in immune cells within the tumour was strongly associated with both early PET changes and improved treatment outcomes.
The researchers emphasise that these findings now need to be validated in larger studies. Future work will aim to confirm these results in broader patient groups and explore more accessible imaging approaches, such as ultrasound, alongside PET and MRI.
Sheeba Irshad, professor of cancer immunology at King’s College London and lead of the Breast Cancer Now KCL Research Unit, said:
“In patients who had PET scans both before treatment and after the first cycle, we found that this early scan could predict whether they were likely to achieve a complete response by the end of treatment. These findings highlight the potential of early imaging to guide treatment decisions, and now need to be validated in larger, modern clinical trials.”
Andrew Tutt, professor of breast oncology at The Institute of Cancer Research, London, said:
“Research that helps us determine early who is already benefitting from standard neoadjuvant chemotherapy and who might benefit from clinical trials to find better treatments is vital. This study shows that FDG-PET may have great value in this regard. We hope to be able to design studies that further investigate and validate these findings.”
The study was supported by funding from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, Breast Cancer Now, Cancer Research UK, and Guy’s and St Thomas’ Charity.
We are excited unveil the three finalists competing for one of the Femtech World Awards’ most coveted honours: the Startup of the Year Award, sponsored by Future Fertility.
This award celebrates an early-stage company making a bold impact in women’s health through innovation, vision and execution.
The winner will be announced at our virtual ceremony on 19 June, with the decision made by a representative from category sponsor Future Fertility.
Congratulations to the shortlist and thank you to everyone who entered or nominated.
Startup of the Year Shortlist
Hello Inside is the first women’s health AI company to turn daily metabolic signals into outcomes women feel and healthcare systems reimburse.
Women’s health has long been under-researched, and current AI benchmarks fail on women’s health questions roughly sixty percent of the time.
Hello Inside built the architecture to close that gap.
Across four years and 12,000+ validated metabolic profiles, three in four women improve at least one symptom within ninety days.
They lose four kilograms in three months, moving from overweight into the healthy range. In a clinical study with Alisa Vitti’s Flo Living, 91.9 per cent reduced PMS burden within sixty days.
U-Ploid is an early-stage biotechnology company tackling one of the most fundamental challenges in fertility care: the sharp, age-related decline in egg quality that limits outcomes across IVF and egg freezing.
While much of the field focuses on improving assessment and selection, U-Ploid is developing a first-in-class therapeutic approach designed to improve egg quality itself by addressing the biological causes of age-related chromosomal errors.
Supported by strong preclinical evidence and now advancing into human studies, U-Ploid combines scientific rigour, regulatory discipline and long-term vision to help redefine what is possible in fertility care.
Gestational diabetes is a strong risk factor for future type 2 diabetes, even in women with normal pre-pregnancy weight, according to a study at the University of Gothenburg.
The researchers call for earlier testing and better follow-up.
“Our results show that gestational diabetes functions as a kind of stress test for the body’s ability to manage blood sugar, and identifies women with a greatly increased risk of future type 2 diabetes”, said Jon Edqvist, PhD and affiliated to research at the University of Gothenburg, and operating room nurse at Sahlgrenska University Hospital.
Gestational diabetes is a special type of diabetes that can affect pregnant women.
The condition is defined as elevated blood sugar levels, without previously known diabetes. Treatment involves self-monitoring of blood sugar, advice on lifestyle habits and, if necessary, medication.
Identifying gestational diabetes is important because the disease increases the risk of complications such as preeclampsia, the need for a cesarean section and high birth weight for the baby.
Those who have had gestational diabetes are also at higher risk of later developing type 2 diabetes.
In the current study, published in eClinicalMedicine, researchers now show that gestational diabetes is a strong indicator of future risk of developing type 2 diabetes, even in women with normal weight before pregnancy.
Elevated risk even with normal weight
The study is based on data from the Medical Birth Registry on just over 1.15 million first-time mothers in Sweden, who gave birth between 1987 and 2019. 16,870 women with confirmed gestational diabetes were compared with age-matched women without the diagnosis. The median follow-up period was nine years.
The results show that women with a BMI of 35 and above, i.e. severe obesity, had an almost tenfold increased risk of developing gestational diabetes compared to women with normal weight.
The risk of subsequent type 2 diabetes also increased with higher BMI, but it was significantly increased even with normal weight, which the researchers describe as particularly worrying.
More follow-up and more studies
The researchers behind the study welcome the recently updated recommendations on gestational diabetes in Sweden, where a higher proportion of pregnant women at increased risk are expected to be offered testing earlier in pregnancy, and if necessary, interventions.
“Diagnostics and care of gestational diabetes have looked very different in different parts of the country,” said Annika Rosengren, professor at the University of Gothenburg.
“There is a need for both improved follow-up after gestational diabetes, and more studies that investigate how such follow-up affects future health and prognosis”
Entrepreneur4 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Insight4 weeks agoWhy the UK’s fertility rate keeps falling – and what it means if you’re trying now
Wellness4 weeks agoWomen’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage
Opinion3 weeks agoWhat Maternal Mental Health Month reveals about where postpartum support actually breaks down
Fertility4 weeks agoToxins and climate harms having ‘alarming’ effect on fertility, research warns
News3 weeks agoNIH Grant terminations disproportionately impact minority scientists, research finds
Adolescent health3 weeks agoWUKA brings Period-Positive Pool Party to London Aquatics Centre to keep girls swimming through puberty
Fertility4 weeks agoResearcher explores weight loss jab impact on PCOS